SEC Form 4 · accession 0001144204-15-034884
Synthetic Biologics, Inc. · SYN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven A Shallcross
Officer — Chief Financial Officer
Period of report
Jun 1, 2015
Accepted (ET)
Jun 1, 2015 · 4:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000894158
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $2.16 | Jun 1, 2015 | A | 900,000 | A | Jul 1, 2015 | May 31, 2025 | Common Stock | 900,000 | 900,000 | D |
Explanation of responses
- F1These options will vest monthly on a pro rated basis over 36 consecutive months.